• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: THERAKOS CELLEX PHOTOPHERESIS SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

THERAKOS CELLEX PHOTOPHERESIS SYSTEM Back to Search Results
Model Number NOT APPLICABLE
Device Problems Partial Blockage (1065); Device Displays Incorrect Message (2591)
Patient Problems Low Blood Pressure/ Hypotension (1914); Nausea (1970); Blood Loss (2597)
Event Date 11/22/2017
Event Type  malfunction  
Manufacturer Narrative
The system was used for treatment.This case is reportable as a mdr due to the reportable malfunction of the clot in the return line.Since this reportable malfunction is only associated with the kit, this mdr will only be against the kit.A batch record review of kit lot f238 was conducted.There were no non-conformances associated with this lot.This lot met all release requirements.A review of kit lot f238 for the reported complaint issue shows no trends.Trends were reviewed for complaint categories, alarm #17: return pressure, clot observed, nausea, and hypotension.No trends were detected for these complaint categories.The assessment is based on information available at the time of the investigation.No product was returned for investigation; therefore, it could not be determined if the product met specification based solely on the information provided by the customer.Complaints are monitored through tracking and trending.If a trend is detected, further investigation will be conducted.(b)(4).
 
Event Description
The customer called to report alarm #17: return pressure alarms and clot observed during a single needle mode extracorporeal photopheresis (ecp) treatment procedure.The customer stated that multiple alarm 17: return pressure alarms occurred after 405 ml of whole blood processed.The customer reported that they had to pause the treatment for more than ten minutes without any movement of the fluid within the kit due to losing the patient's access.The customer stated that when they disconnected the patient's access, they observed clotting in the return line.The customer reported that the treatment was then aborted with no return of blood/products to the patient.The customer stated that the patient's extracellular volume was -109 ml at this moment.The customer reported that the patient complained about nausea after the event.The customer also stated that the patient experienced hypotension and as a result the patient received a 500 ml saline infusion.The customer reported that the patient stabilized with the provided 500 ml saline infusion and underwent another ecp treatment procedure the following day without any issues.The customer stated that the patient was in stable condition.The customer reported that the patient was also being treated with a 25gr infusion of kiovig along with the patient's ecp treatment procedure.The customer stated that kiovig is an immunglobulin, and it is part of the patient's over all treatment.The customer reported that the kiovig infusion was given along with the patient's ecp treatment but over another venous access.The customer stated that the patient's physician has now decided to no longer perform the patient's kiovig infusions in parallel with the patient's ecp treatments.The customer reported that heparin was used as the anticoagulant for this treatment at a ratio of 8.1 (10000 iu in 500 ml saline).The customer stated that they did not want to return the kit for investigation.The kit was not returned for investigation.This medwatch is for the reportable malfunction of the clot in the return line.The adverse events, nausea and hypotension, were submitted under medwatch 2523595-2017-00236.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CELLEX PHOTOPHERESIS SYSTEM
Type of Device
CELLEX PHOTOPHERESIS SYSTEM
Manufacturer (Section D)
THERAKOS
bedminster NJ
Manufacturer (Section G)
THERAKOS, INC.
10 north high street
suite 300
west chester PA 19380
Manufacturer Contact
megan vernak
1425 us route 206
bedminster, NJ 07921
MDR Report Key7128040
MDR Text Key96052793
Report Number2523595-2017-00235
Device Sequence Number1
Product Code LNR
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
P860003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Reporter Occupation Nurse
Type of Report Initial
Report Date 12/19/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Nurse
Device Expiration Date07/01/2019
Device Model NumberNOT APPLICABLE
Device Catalogue NumberCLXECP
Device Lot NumberF238
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 11/22/2017
Initial Date FDA Received12/19/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured07/12/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age61 YR
Patient Weight91
-
-